Regulation FD Disclosure

Filing Summary

Registrant: Coeptis Therapeutics Holdings, Inc. The provided metadata identifies “Z Squared Inc.,” but the filing names Coeptis Therapeutics Holdings, Inc. as the registrant.

Form and date: Form 8-K filed December 5, 2023, under Item 7.01 (Regulation FD Disclosure) and Item 9.01(d) (Exhibits).

Business Context and Reporting Period

The company furnished a corporate presentation dated December 5, 2023, which it plans to use in future presentations to investors and analysts. The filing does not report a quarterly or annual financial period.

Financial and Operating Metrics

  • The filing provides no revenue, profit or loss, cash flow, margin, debt, liquidity, or other financial metrics.
  • The filing text does not provide a clear value for any financial measure.
  • The company’s common stock trades under the symbol COEP and its warrants under COEPW on the Nasdaq Capital Market.

Material Changes Versus Prior Period

The filing does not disclose financial or operational changes versus a prior comparable period. It only reports the posting and furnishing of the corporate presentation.

Guidance, Outlook, Risks, and Unusual Items

  • The presentation may be used in future investor and analyst presentations.
  • The company states that the furnished information is not necessarily material or complete and should not be relied upon as the basis for an investment decision.
  • The information is presented as of December 5, 2023, and the company assumes no obligation to update it.
  • Item 7.01 information is furnished, not filed for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into other filings unless expressly stated.

Investor Verification Items

  • Review Exhibit 99.1, the company’s corporate presentation, for the underlying business, pipeline, strategic, and risk disclosures.
  • Confirm the registrant identity because the supplied metadata differs from the entity named in the filing.
  • Consult the company’s periodic reports for current financial condition, cash runway, debt, liquidity, and operating results.
  • Distinguish forward-looking or presentation-based statements from reported historical results.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.